Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuropsychological Tests | 35 | 2016 | 237 | 7.240 |
Why?
|
| Geriatric Assessment | 17 | 2014 | 87 | 3.980 |
Why?
|
| Cognition Disorders | 15 | 2013 | 181 | 3.260 |
Why?
|
| Intelligence | 7 | 2008 | 27 | 1.710 |
Why?
|
| Residence Characteristics | 11 | 2013 | 101 | 1.590 |
Why?
|
| Psychometrics | 12 | 2016 | 117 | 1.320 |
Why?
|
| Reproducibility of Results | 25 | 2015 | 750 | 1.260 |
Why?
|
| Aged | 30 | 2016 | 5221 | 1.160 |
Why?
|
| Intelligence Tests | 5 | 2006 | 25 | 1.060 |
Why?
|
| Brain Diseases | 6 | 2006 | 35 | 1.020 |
Why?
|
| Cognition | 7 | 2011 | 298 | 1.010 |
Why?
|
| Wechsler Scales | 7 | 2015 | 11 | 0.920 |
Why?
|
| Aged, 80 and over | 21 | 2016 | 1940 | 0.910 |
Why?
|
| Visual Perception | 5 | 2013 | 44 | 0.830 |
Why?
|
| Male | 38 | 2016 | 13019 | 0.760 |
Why?
|
| Demography | 10 | 2006 | 91 | 0.750 |
Why?
|
| Female | 43 | 2016 | 14633 | 0.740 |
Why?
|
| Psychomotor Performance | 7 | 2011 | 72 | 0.720 |
Why?
|
| Alzheimer Disease | 4 | 2013 | 211 | 0.710 |
Why?
|
| Verbal Behavior | 4 | 2010 | 9 | 0.690 |
Why?
|
| Predictive Value of Tests | 15 | 2010 | 472 | 0.690 |
Why?
|
| Educational Status | 9 | 2011 | 110 | 0.650 |
Why?
|
| Aging | 5 | 2007 | 952 | 0.630 |
Why?
|
| Verbal Learning | 3 | 2006 | 11 | 0.620 |
Why?
|
| Humans | 44 | 2016 | 27115 | 0.580 |
Why?
|
| Longitudinal Studies | 8 | 2014 | 404 | 0.580 |
Why?
|
| Brain Damage, Chronic | 3 | 2004 | 4 | 0.560 |
Why?
|
| Memory, Short-Term | 3 | 2014 | 62 | 0.550 |
Why?
|
| Algorithms | 5 | 2006 | 422 | 0.540 |
Why?
|
| Reference Values | 9 | 2011 | 199 | 0.530 |
Why?
|
| Memory Disorders | 2 | 2008 | 47 | 0.520 |
Why?
|
| Sensitivity and Specificity | 8 | 2013 | 508 | 0.520 |
Why?
|
| Age Factors | 9 | 2011 | 721 | 0.470 |
Why?
|
| Independent Living | 1 | 2014 | 14 | 0.450 |
Why?
|
| Attention | 8 | 2015 | 90 | 0.430 |
Why?
|
| Cognitive Dysfunction | 2 | 2013 | 259 | 0.410 |
Why?
|
| Regression Analysis | 7 | 2008 | 209 | 0.410 |
Why?
|
| Middle Aged | 14 | 2016 | 6899 | 0.390 |
Why?
|
| Mental Recall | 2 | 2007 | 45 | 0.370 |
Why?
|
| Sex Characteristics | 1 | 2010 | 163 | 0.340 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 43 | 0.330 |
Why?
|
| Language | 5 | 2013 | 62 | 0.330 |
Why?
|
| Mental Processes | 2 | 2005 | 16 | 0.300 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 27 | 0.290 |
Why?
|
| Adult | 13 | 2016 | 7490 | 0.280 |
Why?
|
| Mental Disorders | 2 | 2013 | 104 | 0.250 |
Why?
|
| Functional Laterality | 2 | 2004 | 62 | 0.240 |
Why?
|
| Problem Solving | 1 | 2005 | 28 | 0.240 |
Why?
|
| Speech Perception | 1 | 2005 | 28 | 0.240 |
Why?
|
| Disease | 1 | 2004 | 15 | 0.240 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 37 | 0.240 |
Why?
|
| Adolescent | 6 | 2013 | 2988 | 0.230 |
Why?
|
| Psychological Theory | 1 | 2004 | 29 | 0.230 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 298 | 0.230 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 988 | 0.230 |
Why?
|
| Analysis of Variance | 4 | 2010 | 388 | 0.220 |
Why?
|
| Cluster Analysis | 2 | 2014 | 119 | 0.210 |
Why?
|
| Memory | 3 | 2013 | 71 | 0.210 |
Why?
|
| Self Report | 2 | 2014 | 116 | 0.210 |
Why?
|
| Time Factors | 5 | 2014 | 1570 | 0.200 |
Why?
|
| African Americans | 1 | 2003 | 350 | 0.190 |
Why?
|
| Trail Making Test | 1 | 1999 | 2 | 0.170 |
Why?
|
| Parkinson Disease | 2 | 2016 | 38 | 0.150 |
Why?
|
| Malingering | 2 | 2011 | 8 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 2 | 2008 | 46 | 0.140 |
Why?
|
| Oklahoma | 2 | 2014 | 978 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2005 | 705 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2010 | 862 | 0.130 |
Why?
|
| Sex Factors | 2 | 2010 | 452 | 0.130 |
Why?
|
| Age Distribution | 2 | 2006 | 70 | 0.130 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 1997 | 48 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 445 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 299 | 0.110 |
Why?
|
| Indocyanine Green | 4 | 1997 | 14 | 0.110 |
Why?
|
| Neurocognitive Disorders | 1 | 1993 | 3 | 0.110 |
Why?
|
| Health Status | 1 | 2014 | 145 | 0.100 |
Why?
|
| Depression | 2 | 2006 | 212 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 39 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2013 | 230 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 367 | 0.100 |
Why?
|
| Dementia | 2 | 2010 | 90 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 290 | 0.080 |
Why?
|
| Psychological Tests | 1 | 2008 | 21 | 0.070 |
Why?
|
| Photosensitizing Agents | 3 | 1997 | 33 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 144 | 0.070 |
Why?
|
| Sclera | 1 | 1987 | 11 | 0.070 |
Why?
|
| Needles | 1 | 1987 | 26 | 0.070 |
Why?
|
| Laser Therapy | 1 | 1987 | 30 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2016 | 2453 | 0.070 |
Why?
|
| Personnel Management | 1 | 2006 | 4 | 0.070 |
Why?
|
| Neuropsychology | 1 | 2006 | 10 | 0.070 |
Why?
|
| Allied Health Personnel | 1 | 2006 | 14 | 0.070 |
Why?
|
| Reference Standards | 1 | 2006 | 54 | 0.070 |
Why?
|
| Bias | 1 | 2006 | 40 | 0.070 |
Why?
|
| Young Adult | 1 | 2013 | 2625 | 0.060 |
Why?
|
| Repression, Psychology | 1 | 2005 | 5 | 0.060 |
Why?
|
| Paired-Associate Learning | 1 | 2005 | 6 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2005 | 8 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 77 | 0.060 |
Why?
|
| Observer Variation | 1 | 2004 | 43 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2003 | 20 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2004 | 95 | 0.050 |
Why?
|
| Vocabulary | 1 | 2003 | 6 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2003 | 53 | 0.050 |
Why?
|
| Reading | 1 | 2003 | 17 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 148 | 0.050 |
Why?
|
| Lasers | 3 | 1997 | 67 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2160 | 0.050 |
Why?
|
| Brain | 1 | 2007 | 710 | 0.050 |
Why?
|
| Discriminant Analysis | 2 | 2010 | 16 | 0.050 |
Why?
|
| Chitin | 1 | 1997 | 10 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 1997 | 63 | 0.030 |
Why?
|
| Rats, Inbred WF | 4 | 1997 | 11 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 1996 | 30 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1995 | 13 | 0.030 |
Why?
|
| Photochemotherapy | 1 | 1996 | 40 | 0.030 |
Why?
|
| Luria-Nebraska Neuropsychological Battery | 1 | 1993 | 1 | 0.030 |
Why?
|
| Rats | 4 | 1997 | 1554 | 0.020 |
Why?
|
| Auditory Perception | 1 | 1991 | 11 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2010 | 9 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1987 | 9 | 0.020 |
Why?
|
| Fluorescein | 1 | 1987 | 6 | 0.020 |
Why?
|
| Silver | 1 | 1987 | 21 | 0.020 |
Why?
|
| Equipment Design | 1 | 1987 | 211 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 41 | 0.010 |
Why?
|
| Animals | 4 | 1997 | 10078 | 0.010 |
Why?
|
| Motivation | 1 | 2003 | 209 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1997 | 15 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1997 | 88 | 0.010 |
Why?
|
| Chitosan | 1 | 1997 | 31 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 310 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1996 | 35 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 239 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1995 | 84 | 0.010 |
Why?
|